Skip to content

POPPIE: Pilot study Of midwifery Practice in Preterm birth Including women's Experiences

POPPIE: Pilot study Of midwifery Practice in Preterm birth Including women's Experiences

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37733900
Enrollment
350
Registered
2017-08-21
Start date
2017-05-11
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Reproductive health and childbirth, Primary sub-specialty: General Obstetrics/ Midwifery

Interventions

The allocation ratio of intervention to control will be 1:1. Randomisation will be managed via a secure web-based randomisation facility hosted by MedSciNet which will write the randomisation program

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Asymptomatic pregnant women with singleton pregnancy and = 24 weeks' gestation and identified at risk of PTB fulfilling one or more of the following criteria: 1. Cervical surgery (such as cone biopsy, LLETZ) 2. Uterine abnormality (such as bicornuate uterus) 3. Previous short cervix 4. Short cervix this pregnancy (14 weeks) 9. Smoking at booking

Exclusion criteria

Exclusion criteria: 1. > 24 weeks’ gestation 2. Aged < 19 years old at recruitment 3. Unable/unwilling to give informed consent 4. Multiple pregnancy 5. Resides outside the catchment area covered by Lewisham Hospital 6. Receiving care from an specialist team already (e.g., teenagers, women suffering severe mental health illness, domestic violence or human trafficking; women with pre-existing diabetes, HIV, hepatitis)

Design outcomes

Primary

MeasureTime frame
The initiation of the following interventions related to the prevention and/or management of preterm labour and birth: antibiotics for UTIs, smoking cessation and domestic violence referrals, transvaginal scan assessments of the cervix, fetal fibronectin assessments, cerclage insertion, progesterone administration, corticosteroid administration, magnesium sulphate administration, admission for observation or in utero transfer; Timepoint(s): following birth

Secondary

MeasureTime frame
1. Recruitment and attrition rates and acceptability to women, healthcare professionals and stakeholders; Timepoints: at baseline/randomisation and in mid and post-implementation 2. Health in pregnancy: other complications; Timepoint: following birth 3. Labour and birth outcomes; Timepoint: following birth 4. Maternal and neonatal postnatal outcomes; Timepoint: following birth 5. Measure of implementation; Timepoints: early, mild and post-implementation 6. Measure of quality of care; Timepoint: 4/6 weeks after birth 7. Measure of women’s experience (trust, stress, system responsiveness, and safety); Timepoint: 4/6 weeks after birth 8. Assessment of psycho-social health; Timepoints: at baseline/randomisation and 4/6 weeks after birth 9. Health economic analysis of cost and resource use for mothers and infants; Timepoint: post-implementation

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 3, 2026